APF
DGX icon

Alaska Permanent Fund’s Quest Diagnostics DGX Stock Holding History

Alaska Permanent Fund’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-414
Closed -$73.8K – 125
2025
Q1 		$73.8K Hold
414
– – ﹤0.01% 449
2024
Q4 		$62.5K Hold
414
– – ﹤0.01% 451
2024
Q3 		$64.3K Hold
414
– – ﹤0.01% 455
2024
Q2 		$58.9K Sell
414
-241
-37% -$33K ﹤0.01% 455
2024
Q1 		$87.2K Buy
655
+413
+171% +$53.6K ﹤0.01% 465
2023
Q4 		$33.4K Buy
242
+107
+79% +$14.1K ﹤0.01% 441
2023
Q3 		$16.5K Sell
135
-127
-48% -$16.9K ﹤0.01% 402
2023
Q2 		$36.8K Buy
+262
New +$36.1K ﹤0.01% 387
2022
Q4 		$58K Sell
368
-226
-38% -$32.5K ﹤0.01% 356
2022
Q3 		$73K Sell
594
-119
-17% -$15.7K ﹤0.01% 349
2022
Q2 		$95K Sell
713
-19,087
-96% -$2.6M ﹤0.01% 348
2022
Q1 		$2.71M Hold
19,800
– – 0.05% 89
2021
Q4 		$2.67M Hold
19,800
– – 0.05% 97
2021
Q3 		$2.88M Hold
19,800
– – 0.06% 50
2021
Q2 		$2.61M Buy
+19,800
New +$2.59M 0.05% 52

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alaska Permanent Fund's DGX Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 414 shares — an estimated $73.8K sold.

Alaska Permanent Fund first reported a position in DGX in Q2 2021 and held it in 15 quarters. The position peaked at $2.88M in Q3 2021. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Alaska Permanent Fund reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Alaska Permanent Fund sold 414 Quest Diagnostics shares in Q2 2025, an estimated $73.8K.
  • Alaska Permanent Fund first reported a position in Quest Diagnostics in Q2 2021 and held it in 15 quarters.
  • Alaska Permanent Fund's Quest Diagnostics position peaked at $2.88M in Q3 2021.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.